A call to
Withdraw the experimental gene-based treatment to the general public and especially children
We, the Covid Medical Network and co-signatories, are writing to you to follow up on prior correspondence to ATAGI, the TGA and the Health Minister, and FOIA requests to the TGA, where answers have either been not forthcoming or have indicated the TGA has lacked critical information for making its provisional approval of the gene-based vaccines, namely Pfizer’s BNT162b2 & Comirnaty, AstraZeneca’s ChAdOx1-S and Moderna’s Spikevax/mRNA-1273.
This letter pertains to:
- Correspondence you and the TGA received that the Pfizer (and AstraZeneca and Moderna) data via the companies themselves or via the FDA was likely too limited in scope to make a proper determination of safety and efficacy.
- FOIA requests to the TGA with respect to reproductive toxicology issues that have been responded to late and with heavily redacted documents.
- FOIA request with respect to micro-RNA sequences and related molecular genetic issues as to whether the TGA had assessed these.
- Peer-reviewed published in vitro research that gene-based vaccine generated spike proteins can migrate into human cell nuclei to disrupt DNA repair mechanisms, and vaccine-derived RNA can be reverse transcribed with evidence pointing to possible integration of this sequence into human genome.
- That a release of some Pfizer data from a FOIA request to the FDA in the US indicated high adverse events reporting by 28 February 2021.
- Analysis of the TGA’s own Database of Adverse Events Notifications (DAEN) data and what Australian clinicians are increasingly witnessing as a high rate of injuries from these gene-based vaccines.
Finish reading:
https://www.covidmedicalnetwork.com/open-letters/open-letter-to-atagi.aspx